Pluristem Therapeutics (PSTI) Receives South African Patent for Harvesting Adherent Stromal Cells
Tweet Send to a Friend
Pluristem Therapeutics (NASDAQ: PSTI) has been issued Patent No. 2013/07160, titled "Methods and Systems for Harvesting Adherent Stromal Cells", in ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE